Evidence map›Paper›PMID 27630576›Full record

ArticleFrontiers in physiology2016

MORN5 Expression during Craniofacial Development and Its Interaction with the BMP and TGFβ Pathways.

Petra Cela, Marek Hampl, Katherine K Fu, Michaela Kunova Bosakova, Pavel Krejci, Joy M Richman, Marcela Buchtova

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Mouse radial spoke 3 is a metabolic and regulatory hub in cilia.Nature structural & molecular biology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Petra CelaInstitute of Animal Physiology and Genetics, v.v.i., Academy of Sciences of the Czech RepublicBrno, Czech Republic; Department of Animal Physiology and Immunology, Institute of Experimental Biology, Masaryk UniversityBrno, Czech Republic.
Marek HamplInstitute of Animal Physiology and Genetics, v.v.i., Academy of Sciences of the Czech RepublicBrno, Czech Republic; Department of Animal Physiology and Immunology, Institute of Experimental Biology, Masaryk UniversityBrno, Czech Republic.
Katherine K FuLife Sciences Institute, University of British Columbia Vancouver, BC, Canada.
Michaela Kunova BosakovaDepartment of Biology, Faculty of Medicine, Masaryk University Brno, Czech Republic.
Pavel KrejciDepartment of Biology, Faculty of Medicine, Masaryk UniversityBrno, Czech Republic; International Clinical Research Center, St. Anne's University HospitalBrno, Czech Republic.
Joy M RichmanLife Sciences Institute, University of British Columbia Vancouver, BC, Canada.
Marcela BuchtovaInstitute of Animal Physiology and Genetics, v.v.i., Academy of Sciences of the Czech RepublicBrno, Czech Republic; Department of Animal Physiology and Immunology, Institute of Experimental Biology, Masaryk UniversityBrno, Czech Republic.
Masaryk University · CZUniversity of British Columbia · CASt. Anne's University Hospital Brno · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MORN5 (MORN repeat containing 5) is encoded by a locus positioned on chromosome 17 in the chicken genome. The MORN motif is found in multiple copies in several proteins including junctophilins or phosphatidylinositol phosphate kinase family and the MORN proteins themselves are found across the animal and plant kingdoms. MORN5 protein has a characteristic punctate pattern in the cytoplasm in immunofluorescence imaging. Previously, MORN5 was found among differentially expressed genes in a microarray profiling experiment of the chicken embryo head. Here, we provided in situ hybridization to analyse, in detail, the MORN5 expression in chick craniofacial structures. The expression of MORN5 was first observed at stage HH17-18 (E2.5). MORN5 expression gradually appeared on either side of the primitive oral cavity, within the maxillary region. At stage HH20 (E3), prominent expression was localized in the mandibular prominences lateral to the midline. From stage HH20 up to HH29 (E6), there was strong expression in restricted regions of the maxillary and mandibular prominences. The frontonasal mass (in the midline of the face) expressed MORN5, starting at HH27 (E5). The expression was concentrated in the corners or globular processes, which will ultimately fuse with the cranial edges of the maxillary prominences. MORN5 expression was maintained in the fusion zone up to stage HH29. In sections MORN5 expression was localized preferentially in the mesenchyme. Previously, we examined signals that regulate MORN5 expression in the face based on a previous microarray study. Here, we validated the array results with in situ hybridization and QPCR. MORN5 was downregulated 24 h after Noggin and/or RA treatment. We also determined that BMP pathway genes are downstream of MORN5 following siRNA knockdown. Based on these results, we conclude that MORN5 is both regulated by and required for BMP signaling. The restricted expression of MORN5 in the lip fusion zone shown here supports the human genetic data in which MORN5 variants were associated with increased risk of non-syndromic cleft lip with or without cleft palate.

Indexed as

BMPcleft lipfrontonasal massmandibular prominencemaxillary prominence

Identifiers

PMID27630576
PMCPMC5005375
OpenAlexW2509355559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.